Adiposity associates with lower plasma resolvin E1 (Rve1): a population study

Barden A, Shinde S, Beilin LJ, Phillips M, Adams L, Bollmann S, Mori TA. 12 Feb 2024 International Journal of Obesity. doi: 10.1038/s41366-024-01482-x

Publication date: 12 Feb 2024

Keywords: cardiovascular disease risk, chronic disease, fatty acids, inflammation

What is already known about this subject:

  • Inadequate inflammation resolution may contribute to persistent low-grade inflammation that accompanies many chronic conditions. Resolution of inflammation is an active process driven by Specialized Pro-resolving Mediators (SPM) that derive from long chain n-3 and n-6 fatty acids.
  • This study examined plasma SPM in relation to sex differences, lifestyle and a broad range cardiovascular disease (CVD) risk factors in 978, 27-year olds from the Australian Raine Study.

What this study adds

  • These results suggests that a deficiency in plasma RvE1 may occur in response to increasing adiposity. This observation could be relevant to ongoing inflammation that associates with CVD and other chronic diseases.
View full publication

Areas of Interest